All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0722-LX173 | Anti-FVIII (X7X173) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X173 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX174 | Anti-FVIII (X7X174) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X174 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX175 | Anti-FVIII (X7X175) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X175 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX176 | Anti-FVIII (X7X176) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X176 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX177 | Anti-FVIII (X7X177) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X177 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX178 | Anti-FVIII (YK3.3.38) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | YK3.3.38 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX179 | Anti-FVIII (YK3.3.40) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | YK3.3.40 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX180 | Anti-FVIII (YK3.3.50) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | YK3.3.50 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX181 | Anti-FVIII (X7X181) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X181 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX182 | Anti-FVIII (X7X182) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X182 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX183 | Anti-FVIII (X7X183) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | human | X7X183 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0722-LX381 | Anti-FVIII (X7X173) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X173 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX382 | Anti-FVIII (X7X174) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X174 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX383 | Anti-FVIII (X7X175) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X175 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX384 | Anti-FVIII (X7X176) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X176 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX385 | Anti-FVIII (X7X177) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X177 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX386 | Anti-FVIII (YK3.3.38) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | YK3.3.38 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX387 | Anti-FVIII (YK3.3.40) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | YK3.3.40 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX388 | Anti-FVIII (YK3.3.50) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | YK3.3.50 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX389 | Anti-FVIII (X7X181) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X181 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION